04/23/2024
7:34 AM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
1:56 PM | Tarsus Pharmaceuticals (Subject)
Trevejo Jose M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/28/2024
1:06 PM | Tarsus Pharmaceuticals (Subject)
Trevejo Jose M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2024
6:03 PM | Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
6:04 PM | Tarsus Pharmaceuticals (Issuer)
Whitfield Dianne C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
6:05 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
6:05 PM | Tarsus Pharmaceuticals (Issuer)
Wahl Bryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/19/2024
6:08 PM | Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
2:44 PM | Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2024
2:44 PM | Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2024
2:47 PM | Tarsus Pharmaceuticals (Subject)
Wahl Bryan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024
4:57 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:45 PM | Tarsus Pharmaceuticals (Issuer)
Wahl Bryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:10 PM | Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:11 PM | Farrow Jeffrey S (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:12 PM | Tarsus Pharmaceuticals (Issuer)
Whitfield Dianne C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2024
4:12 PM | Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:26 PM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
4:17 PM | Tarsus Pharmaceuticals (Filer)
| Form 424B5 | |
02/29/2024
4:08 PM | Tarsus Pharmaceuticals (Filer)
| Form 424B5 | |
02/29/2024
3:32 PM | Tarsus Pharmaceuticals (Filer)
| Form S-3ASR | |
02/27/2024
3:22 PM | Tarsus Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/26/2024
8:18 PM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
6:28 AM | RTW INVESTMENTS, LP (Filed by)
Tarsus Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/09/2024
9:06 AM | MORGAN STANLEY (Filed by)
Tarsus Pharmaceuticals (Subject)
| Form SC 13G | |
02/02/2024
11:40 AM | Cowen Financial Products LLC (Filed by)
Tarsus Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/02/2024
5:05 AM | Tarsus Pharmaceuticals (Subject)
TimesSquare Capital Management, LLC (Filed by)
| Form SC 13G/A | |
01/22/2024
4:05 PM | Paradigm Biocapital Advisors LP (Filed by)
Tarsus Pharmaceuticals (Subject)
| Form SC 13G | |
01/18/2024
3:30 PM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
8:00 AM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
4:08 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
3:23 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023
4:30 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
4:32 PM | Tarsus Pharmaceuticals (Issuer)
Trevejo Jose M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2023
3:49 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2023
2:17 PM | Tarsus Pharmaceuticals (Subject)
Trevejo Jose M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/19/2023
5:30 PM | Goldberg Andrew D. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
8:01 AM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2023
5:27 PM | Tarsus Pharmaceuticals (Issuer)
YARNO WENDY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
3:55 PM | Tarsus Pharmaceuticals (Issuer)
Wahl Bryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
3:58 PM | Tarsus Pharmaceuticals (Issuer)
Whitfield Dianne C. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Protect Yourself While There’s Still Time … (Ad) The next step of the Fed's control is here.
Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week.
Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. |
11/30/2023
3:35 PM | Tarsus Pharmaceuticals (Subject)
Whitfield Dianne C. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2023
11:15 PM | Tarsus Pharmaceuticals (Filer)
| Form EFFECT | |
11/17/2023
3:50 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2023
3:53 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/09/2023
3:00 PM | Tarsus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/20/2023
3:41 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2023
3:26 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/06/2023
4:21 PM | Tarsus Pharmaceuticals (Issuer)
Trevejo Jose M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2023
10:48 AM | Tarsus Pharmaceuticals (Subject)
Trevejo Jose M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/22/2023
4:30 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2023
3:30 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/19/2023
3:25 PM | Morrison Scott W (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/25/2023
4:12 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2023
3:39 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/17/2023
5:02 PM | Lin Elizabeth Yeu (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/25/2023
7:47 AM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/21/2023
4:42 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/21/2023
4:46 PM | Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/20/2023
3:34 PM | Greenstein Leonard M. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/19/2023
3:54 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/19/2023
3:38 PM | Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/14/2023
3:40 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2023
3:48 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/27/2023
3:23 PM | Tarsus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2023
4:56 PM | Goldberg Andrew D. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
4:58 PM | CHAUDHURI BHASKAR (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
5:10 PM | Crane Rosemary A (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
4:42 PM | Tarsus Pharmaceuticals (Issuer)
YARNO WENDY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
4:45 PM | Morrison Scott W (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
4:47 PM | LINK WILLIAM J PHD (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
4:49 PM | Lin Elizabeth Yeu (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:29 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
5:25 PM | CHAUDHURI BHASKAR (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
5:27 PM | Crane Rosemary A (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
5:08 PM | LINK WILLIAM J PHD (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
5:14 PM | Lin Elizabeth Yeu (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
5:18 PM | Goldberg Andrew D. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
5:21 PM | Tarsus Pharmaceuticals (Issuer)
YARNO WENDY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
3:37 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/16/2023
3:48 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/15/2023
4:17 PM | Greenstein Leonard M. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2023
3:52 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2023
4:40 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
6:16 PM | Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
4:56 PM | Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/08/2023
4:40 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023
6:49 PM | Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/06/2023
4:21 PM | Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/19/2023
6:08 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/17/2023
5:02 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144/A | |
Move Your Money Before May 22 (Ad) The SIX WORDS That Could Destroy America... And The Value of Your Savings.
He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals.  Here's where Dr. David Eifrig says to move your money immediately. |
05/17/2023
3:34 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/10/2023
4:17 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/05/2023
2:28 PM | Cowen Financial Products LLC (Filed by)
Tarsus Pharmaceuticals (Subject)
| Form SC 13G | |
05/02/2023
6:06 PM | Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/28/2023
7:01 PM | Farrow Jeffrey S (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 3/A | |
04/26/2023
4:05 PM | Farrow Jeffrey S (Reporting)
Tarsus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
